Date published: 2025-10-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCNQ1 Activators

KCNQ1 activators represent a multifaceted class of chemicals with the capacity to intricately modulate the activity of the KCNQ1 potassium channel, a pivotal component in cellular repolarization and excitability. These activators, distinguished as direct or indirect, hold significant promise for elucidating and manipulating KCNQ1 channel function across various physiological contexts. Direct activators within this class, exemplified by Retigabine and ICA-105665, exert their influence by binding directly to KCNQ1 channels. Retigabine demonstrates its impact by binding to KCNQ1/KCNE1 channels, thereby enhancing their conductance and facilitating potassium efflux, a critical process for repolarization. Similarly, ICA-105665 operates by stabilizing the open state of KCNQ1 channels, a crucial facet for normal cardiac and neuronal function. On the other hand, indirect activators, including Zinc Pyrithione and GW3965, modulate KCNQ1 function by influencing cellular pathways. Zinc Pyrithione inhibits KCNQ1 ubiquitin ligases, impeding the ubiquitination and subsequent degradation of KCNQ1. This leads to an accumulation of KCNQ1 protein levels, further influencing channel activity. GW3965, alternatively, impacts KCNQ1 indirectly by altering cellular cholesterol levels, potentially influencing membrane lipid composition and subsequently affecting KCNQ1 channel activity. The emergence of highly selective activators such as ML277 and VU590 adds a layer of precision to the study of KCNQ1-related channelopathies. ML277, functioning as a direct activator, enhances KCNQ1 channel conductance, contributing to the modulation of cellular excitability. On the other hand, VU590 exhibits specificity by binding to the pore region of the KCNQ1 channel, promoting potassium efflux and facilitating repolarization. In summation, the spectrum of KCNQ1 activators illuminates the intricate nature of potassium channel modulation. Whether through direct binding, modulation of ubiquitination pathways, or influence on cellular lipid composition, these chemicals contribute substantially to our understanding of KCNQ1 channel activation and its implications in maintaining cellular excitability and repolarization.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

L-364,373

103342-82-1sc-204036
sc-204036B
sc-204036C
2.5 mg
5 mg
10 mg
$240.00
$469.00
$877.00
(1)

L-364,373 functions as a potent KCNQ1 modulator, characterized by its ability to stabilize specific ion channel conformations. Its unique binding affinity is influenced by intricate hydrogen bonding and hydrophobic interactions, which fine-tune channel gating dynamics. The compound's distinct electronic properties facilitate rapid charge transfer, impacting ion flow and channel kinetics. Additionally, L-364,373 demonstrates a high degree of selectivity, allowing for targeted modulation of cellular excitability.

GW 3965 hydrochloride

405911-17-3sc-224011
sc-224011A
sc-224011B
5 mg
25 mg
1 g
$137.00
$474.00
$3060.00
(1)

GW3965 indirectly activates KCNQ1 by modulating cholesterol levels. It activates LXR, leading to increased expression of genes involved in cholesterol efflux. This influences membrane lipid composition, potentially impacting KCNQ1 channel activity and promoting repolarization.

NS 1643

448895-37-2sc-204135
sc-204135A
10 mg
50 mg
$121.00
$464.00
3
(1)

NS1643 directly activates KCNQ1 by enhancing channel conductance. It stabilizes the open state of KCNQ1 channels, increasing potassium efflux and promoting repolarization in excitable cells, making it a potential pharmacological tool for modulating KCNQ1 channel function.

Niflumic acid

4394-00-7sc-204820
5 g
$31.00
3
(1)

Niflumic Acid directly activates KCNQ1 by potentiating channel currents. It affects KCNQ1 gating properties, increasing potassium efflux and promoting repolarization in excitable cells. This modulation is crucial for maintaining proper cardiac and neuronal function.

Flupirtine Maleate

75507-68-5sc-218512
10 mg
$101.00
1
(1)

Flupirtine directly activates KCNQ1 by potentiating channel currents. It affects KCNQ1 gating properties, increasing potassium efflux and promoting repolarization in excitable cells. This pharmacological agent holds potential in modulating KCNQ1 function in various physiological contexts.

Zinc

7440-66-6sc-213177
100 g
$47.00
(0)

Zinc Pyrithione indirectly activates KCNQ1 by inhibiting the activity of KCNQ1 ubiquitin ligases, preventing KCNQ1 ubiquitination and degradation. This leads to increased KCNQ1 protein levels, enhancing its presence in the cell membrane and promoting ion channel activity.